Publicaciones (265) Publicaciones de RAUL ORTIZ DE LEJARAZU LEONARDO

2024

  1. Impact on the time elapsed since SARS-CoV-2 infection, vaccination history, and number of doses, on protection against reinfection

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. Evolution of antibody profiles against SARS-CoV-2 in experienced and naïve vaccinated elderly people

    Frontiers in Immunology, Vol. 14

  2. Group 1 and group 2 hemagglutinin stalk antibody response according to age

    Frontiers in Immunology, Vol. 14

  3. Possible Mpox Protection from Smallpox Vaccine-Generated Antibodies among Older Adults

    Emerging Infectious Diseases, Vol. 29, Núm. 3, pp. 656-658

2022

  1. Coinfections of influenza and other respiratory viruses are associated to children

    Anales de Pediatria, Vol. 96, Núm. 4, pp. 334-341

2021

  1. Do Vaccines Need a Gender Perspective? Influenza Says Yes!

    Frontiers in Immunology, Vol. 12

  2. Global influenza surveillance in times of COVID-19: Robbing Peter to pay Paul?

    Revista Clinica Espanola

  3. Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses

    Frontiers in Microbiology, Vol. 12

  4. Social distancing, lockdown and thewide use of mask; a magic solution or a double-edged sword for respiratory viruses epidemiology?

    Vaccines, Vol. 9, Núm. 6

  5. Vigilancia de la gripe y otros virus respiratorios durante la pandemia de Covid-19, un enfoque One Health: la asignatura pendiente (2ª parte)

    Profesión veterinaria, Vol. 24, Núm. 96, pp. 59-70

2020

  1. 50 preguntas y respuestas sobre el coronavirus (Covid-19)

    Amazing Books

  2. Adjuvanted influenza vaccines elicits higher antibody responses against the A(H3N2) subtype than non-adjuvanted vaccines

    Vaccines, Vol. 8, Núm. 4, pp. 1-11

  3. Effect of antiviral treatment in older patients hospitalized with confirmed influenza

    Antiviral Research, Vol. 178

  4. From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain

    PLoS ONE, Vol. 15, Núm. 5

  5. High-dose trivalent influenza vaccine. Efficacy and effectiveness

    Revista Espanola de Quimioterapia, Vol. 33, Núm. 4, pp. 226-239

  6. Retrospective assessment of the antigenic similarity of egg-propagated and cell culture-propagated reference influenza viruses as compared with circulating viruses across influenza seasons 2002–2003 to 2017–2018

    International Journal of Environmental Research and Public Health, Vol. 17, Núm. 15, pp. 1-13

  7. The impact of candidate influenza virus and egg-based manufacture on vaccine effectiveness: Literature review and expert consensus

    Vaccine, Vol. 38, Núm. 38, pp. 6047-6056

  8. Vacunas de gripe

    Pediatria Integral, Vol. 24, Núm. 8, pp. 469-478

2019

  1. Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 74, Núm. 5, pp. 1357-1362

  2. Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain

    Open Forum Infectious Diseases, Vol. 6, Núm. 2